Ilant Health, the value-based obesity treatment company working with employers and health plans to deliver clinical outcomes and reduce the total cost of care, announced it has raised $15 million in Series A funding, bringing its total funding to over $22 million to date. The round was led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, as well as existing investors Celtic, LifeX, and AlphaLab.

Ilant Health is an obesity and cardiometabolic health company, focused on increasing access to treatment while reducing total cost of care for employers and payers through value-based care. Ilant Health provides the single front door for individuals with obesity, delivering end-to-end evidence-based solutions (bariatric surgery, medication, intense behavioral therapy) through a technology-enabled and analytics-driven obesity medicine practice.